GPX3 and renal cell carcinoma: GPX3 methylation was further detected in 77.1% (162/210) of RCC tumors, but only 14.6% (7/48) of adjacent non-malignant renal tissues, indicating that GPX3 methylation is a tumor-specific event involved in tumorigenesis of RCC.